Electrocardiogram Monitoring After the Food and Drug Administration Warnings for Citalopram: Unheeded Alerts?

Electrocardiogram Monitoring After the Food and Drug Administration Warnings for Citalopram: Unheeded Alerts?
复制标题

DOI:
10.1111/jgs.15420
复制
发表时间:
2018-07
影响因子:
6.3
通讯作者:
L. Gerlach;H. M. Kim;M. Yosef;H. Kales;J. Henry;K. Zivin
L. Gerlach;H. M. Kim;M. Yosef;H. Kales;J. Henry;K. Zivin
中科院分区:
医学1区
文献类型:
--
作者:
L. Gerlach;H. M. Kim;M. Yosef;H. Kales;J. Henry;K. Zivin

文献摘要

相似文献

评估2011-12年美国食品和药物管理局(FDA)安全警告前后,退伍军人事务(VA)受益人服用大剂量西酞普兰的心电图(EKG)监测的全国趋势。
To evaluate national trends in electrocardiogram (EKG) monitoring in Veterans Affairs (VA) beneficiaries prescribed high‐dose citalopram before and after the 2011–12 Food and Drug Administration (FDA) safety warnings.